Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an ...

This is the second volume of the Research Topic titled 'Novel Insights into CAR T-cell Associated Neurotoxicity'. You may ...

Amgen’s bispecific T-cell engager (BiTE) led to an ORR of 41% in patients with extensive-stage small cell lung cancer.

NEW YORK, NY, USA and VIENNA, Austria I January 02, 2025 I The boards of directors (each a “Board”) of HOOKIPA Pharma Inc. (“HOOKIPA”) and Poolbeg Pharma plc ...

Extreme caution is being urged after two hikers died in separate incidents on the same Pyrenean trail on New Year's Day. The ...

The boards of directors of Hookipa Pharma (HOOK) and Poolbeg Pharma announced that they have entered into non-binding ...

CAR T-cell therapy represents a groundbreaking advancement in the field of oncology, particularly in the treatment of certain types of blood cancers such as leukemia and lymphoma. This innovative ...

Poolbeg's clinical programmes target large addressable markets including cancer immunotherapy-induced Cytokine Release ...

Curocell launches Limcato, South Koreas first domestic CAR-T cancer therapy Curocell introduces first local CAR-T therapy, ...

INR:1587. which is the best betting app Positive Phase 2 Data from Blueprint Precision Cancer Therapy for Rare Immune Disease The National Medical P ...

INR:0286. football trophies list Development trend of retail pharmacy industry under the new situation Tagrisso's pivotal Phase 3 clinical results show pos ...